| Cyproterone acetate with ethinylestradiol as a risk factor for venous thromboembolism: an epidemiological evaluation. | |
| | |
MedLine Citation:
|
PMID: 15329967 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
|
Authors:
|
Mario Pini |
Related Documents
:
|
2210207 - Enteroscopy and enteroclysis: an improved method for combined procedure. 12184707 - Percutaneous tube cystostomy and vesicular irrigation for treatment of obstructive urol... 10389557 - Does local anaesthetic affect the success rate of intravenous cannulation? 6517087 - Comparative accuracy of five intravenous-fluid controllers. 11985767 - Elite athletes' experiences of the motivational climate: the coach matters. 8060097 - Interference by parvolex with chloride estimation by the ag/agcl method. |
Publication Detail:
|
Type: Comment; Letter |
Journal Detail:
|
Title: Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstétrique et gynécologie du Canada : JOGC Volume: 26 ISSN: 1701-2163 ISO Abbreviation: J Obstet Gynaecol Can Publication Date: 2004 Jul |
Date Detail:
|
Created Date: 2004-08-26 Completed Date: 2004-10-08 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 101126664 Medline TA: J Obstet Gynaecol Can Country: Canada |
Other Details:
|
Languages: eng Pagination: 625; author reply 626 Citation Subset: IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Contraceptives, Oral, Combined
/
adverse effects* Cyproterone Acetate / administration & dosage, adverse effects Ethinyl Estradiol / administration & dosage, adverse effects Female Humans Incidence Italy / epidemiology Risk Factors Thromboembolism / epidemiology*, etiology |
| Chemical | |
Reg. No./Substance:
|
0/Contraceptives, Oral, Combined; 427-51-0/Cyproterone Acetate; 57-63-6/Ethinyl Estradiol |
| Comments/Corrections | |
Comment On:
|
J Obstet Gynaecol Can. 2003 Dec;25(12):1011-8
[PMID:
14663535
]
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Accelerating whole-cell biocatalysis by reducing outer membrane permeability barrier.
Next Document: Extremely high body mass index is not a contraindication to laparoscopic gastric bypass.